Ed has a 25-year career spanning Investment, Venture Capital and Start-Ups, specialising in Healthcare and Technology as an Analyst and Portfolio Manager.
More recently, he was Investment Director in Life Sciences Venture Capital firm, Arix Bioscience, which created a portfolio of Biotechs with differentiated science and world-class teams. Lately he has been working with venture building partnerships to assemble the elements needed for success in early-stage companies.
Ed has an MA in Chemistry and MSc in Management from Oxford University and is a Chartered Financial Analyst.
